| Literature DB >> 28024868 |
Ruta Sahasrabudhe1, Paul Lott1, Mabel Bohorquez2, Ted Toal1, Ana P Estrada2, John J Suarez2, Alejandro Brea-Fernández3, José Cameselle-Teijeiro4, Carla Pinto5, Irma Ramos6, Alejandra Mantilla7, Rodrigo Prieto2, Alejandro Corvalan8, Enrique Norero8, Carolina Alvarez9, Teresa Tapia9, Pilar Carvallo9, Luz M Gonzalez10, Alicia Cock-Rada10, Angela Solano11, Florencia Neffa12, Adriana Della Valle12, Chris Yau13, Gabriela Soares14, Alexander Borowsky15, Nan Hu16, Li-Ji He17, Xiao-You Han18, Philip R Taylor16, Alisa M Goldstein16, Javier Torres6, Magdalena Echeverry2, Clara Ruiz-Ponte3, Manuel R Teixeira19, Luis G Carvajal-Carmona20.
Abstract
Up to 10% of cases of gastric cancer are familial, but so far, only mutations in CDH1 have been associated with gastric cancer risk. To identify genetic variants that affect risk for gastric cancer, we collected blood samples from 28 patients with hereditary diffuse gastric cancer (HDGC) not associated with mutations in CDH1 and performed whole-exome sequence analysis. We then analyzed sequences of candidate genes in 333 independent HDGC and non-HDGC cases. We identified 11 cases with mutations in PALB2, BRCA1, or RAD51C genes, which regulate homologous DNA recombination. We found these mutations in 2 of 31 patients with HDGC (6.5%) and 9 of 331 patients with sporadic gastric cancer (2.8%). Most of these mutations had been previously associated with other types of tumors and partially co-segregated with gastric cancer in our study. Tumors that developed in patients with these mutations had a mutation signature associated with somatic homologous recombination deficiency. Our findings indicate that defects in homologous recombination increase risk for gastric cancer.Entities:
Keywords: Interaction; Stomach; Tumor; WES
Mesh:
Substances:
Year: 2016 PMID: 28024868 PMCID: PMC5367981 DOI: 10.1053/j.gastro.2016.12.010
Source DB: PubMed Journal: Gastroenterology ISSN: 0016-5085 Impact factor: 22.682